期刊文献+

核移位YB-1蛋白、P-gp及PCNA在肝癌中的表达及意义 被引量:3

The expression and significance of YB-1 with nuclear translocation,P-gp and PCNA in hepatocellular carcinoma
下载PDF
导出
摘要 目的探讨核移位YB-1蛋白、P糖蛋白(P-gp)、增殖核抗原(PCNA)在肝细胞肝癌(hepatocellular carcinoma,HCC)组织中的表达及其在肝癌发生发展中的作用。方法采用免疫组化法检测YB-1、P-gp、PCNA蛋白在58例HCC组织、20例正常肝组织中的表达。结果在肝癌组织中核移位YB-1与P-gp、PCNA蛋白阳性率分别为31%(18/58)、83%(48/58)、100%(58/58),与正常肝组织相比有显著差异(P<0.05)。核移位YB-1蛋白及PCNA积分与肝癌病理分级、门静脉癌栓、肿瘤大小有关(P<0.05);P-gp蛋白与肝癌病理分级有关(P<0.05)。核移位YB-1蛋白与P-gp、PCNA蛋白表达呈正相关(P<0.05)。结论 YB-1蛋白可能通过核移位途径上调P-gp、PCNA蛋白表达,从而促进肝癌的发生发展及其恶性表型的维持,YB-1蛋白有可能成为肝癌治疗的新靶点。 Objective To observe expression levels of YB-1 protein with nuclear translocation, P-gp, PCNA protein in hepatocellular carcinoma (HCC) tissues, and explore their significance and correlation. Methods Immunochemistrywas performed in 58 HCC tissues and 20 normal liver tissues to study the levels of YB-1 protein with nuclear transloca- tion, P-gp and PCNA protein. Results Positive rates of YB-1 with nuclear translocation, P-gp, PCNA protein ap- peared at high levels in immunochemistry of HCC 3 1% (18/58) , 83% (48/58) , 100% (58/58) compared with normal liver tissues (P 〈 0.05). Furthermore, the nuclear expression of YB-1 and the PCNA were significantly correlated with the pathological grade, tumor size and portal venous invasion (P 〈 0.05 ). P-gp was correlated with the pathologicalgradeonly (P 〈 0.05). The protein of YB-1 with nuclear translocation was significantly correlated with P-gp and PCNA protein (P 〈 0.05). Conclusion The data demonstrate that YB-1 protein with nuclear translocation may up regulate the P-gp, PCNA protein which may be involved in human HCC carcinogenesis and malignant phenotype, and YB-1 may be a special treatment target for HCC.
出处 《胃肠病学和肝病学杂志》 CAS 2011年第12期1084-1087,共4页 Chinese Journal of Gastroenterology and Hepatology
关键词 YB-1 P糖蛋白 增殖核抗原 肝细胞肝癌 核移位 YB-1 P-gp PCNA Hepatocellular carcinoma Nuclear translocation
  • 相关文献

参考文献9

  • 1Kohno K,Izumi H,Uchiumi T,et al.The pleiotropic functions of theY-box-binding protein,YB-1[J].Biol Essays,2003,25(7):691-698.
  • 2Gu C,Oyama T,Osaki T,et al.Expression of Y box-binding protein 1correlates with DNA topoisomerase II alpha and proliferating cell nucle-ar antigen expression in lung cancer[J].Anticancer Res,2001,21(4A):2357-2362.
  • 3Jurchott K,Bergmann S,Stein U,et al.YB-1 as a cellcycle-regulatedtranscription factor facilitating cyclin A and cyclinB1 gene expression[J].J Biol Chem,2003,278(30):27988-27996.
  • 4Ohga T,Uchiumi T,Makino Y,et al.Direct involvement of the Y-boxbinding protein YB-1 in genotoxic stress-induced activation of the hu-man multidrug resistance 1 gene[J].J Biol Chem,1998,273(11):5997-6000.
  • 5Oda Y,Ohishi Y,Basaki Y.Prognostic implications of the nuclearlo-calization of Y-box-binding protein-1 and CXCR4 expression in ovariancancer their correlation with activated Akt,LRP/MVP andP-glycopro-tein expression[J].Cancer Sci,2007,98(7):1020-1026.
  • 6杨靖,许文林,李娟,弓晋灵,吴晓君,陈巧云,王法春.YB-1表达对乳腺癌细胞迁移和侵袭能力的影响[J].江苏大学学报(医学版),2010,20(3):207-211. 被引量:6
  • 7Gimenez-Bonafe P,Fedoruk M,Whitmore T,et al.YB-1 is upregulat-ed during prostate cancer tumor progression and increases P-Glycopro-tein activity[J].The Prostate,2004,59(3):337-349.
  • 8Dahl E,En-Nia A,Wiesmann F,et al.Nuclear detection of Y-boxprotein-1(YB-1)closely associates with progesterone receptor negativi-ty and is a strong adverse survival factor in human breast cancer[J].BMC Cancer,2009,9:410.
  • 9Gessner C,Woischwill C,Schumacher A,et al.Nuclear YB-1 expres-sion as a negative prognostic marker in nonsmall cell lungcancer[J].Eur Respir,2004,23(1):14-19.

二级参考文献7

  • 1Giménez-Bonafé P,Fedoruk MN,Whitmore TG,et al.YB-1 is upregulated during prostate cancer tumor progression and increases P-glycoprotein activity[J].Prostate,2004,59(3):337-349.
  • 2Huang J,Tan PH,Li KB,et al.Y-box binding protein,YB-1,as a marker of tumor aggressiveness and response to adjuvant chemotherapy in breast cancer[J].Int J Oncol,2005,26(3):607-613.
  • 3Kotaro S,Kenji S,Toshihiro O,et al.Nuclear expression of the Y-box binding protein,YB-1,as a novel marker of disease progression in non-small cell lung cancer[J].Clin Cancer Res,2001,7(10):3151-3155.
  • 4Matsumoto K,Abiko S,Ariga H.Transcription regulatory complex including YB-1 controls expression of mouse matrix metalloproteinase-2 gene in NIH3T3 cells[J].Biol Pharm Bull,2005,28(8):1500-1504.
  • 5Mertens PR,Harendza S,Pollock AS,et al.Glomerular mesangial cell-specific transactivation of matrix metalloproteinase 2 transcription is mediated by YB-1[J].J Biol Chem,1997,272(36):22905-22912.
  • 6Samuel S,Beifuss KK,Bernstein LR.YB-1 binds to the MMP-13 promoter sequence and represses MMP-13 transactivation via the AP-1 site[J].Biochim Biophys Acta,2007,1769(9/10):525-531.
  • 7刘佳,瞿存业,马蕾娜,石文芳,钱其军.YB-1与肿瘤发生及治疗[J].生物化学与生物物理进展,2008,35(7):744-750. 被引量:4

共引文献5

同被引文献18

  • 1郭双平,王丽,王文亮,李擒龙,王文勇,张静.抑癌基因PTEN在肝癌组织中的突变及其对肝癌细胞增殖和凋亡的调控作用[J].中华病理学杂志,2006,35(8):467-472. 被引量:25
  • 2Tran TP, Kim HG, Choi JH, et al. Reversal of P- glycoprotein- mediated multidrug resistance is in- duced by mollugin in MCF-7/adriamycin cells[J]. Phytomedicine, 2013, 20(7): 622-631.
  • 3Zhao LH, Ma ZX, Zhu J, et al. Characterizaion of polysaccharide from Astragalus radix as the macro- phage stimulator [J]. Cell Immunol, 2011, 271 (2) : 329-34.
  • 4Wang X, Xu X, Tao W, et al. A systems biology approach to uncovering pharmacological synergy in herbal medicines with applications to cardiovascular disease[J]. Evid Based Complement Alternat Med, 2012, doi:10. 1155/ 2012/519031.
  • 5Yuan YM, Gao JW, Shi Z, et al. Herb-drug phar- macokinetic interaction between radix astragali and pioglitazone in rats [J]. J Ethnopharmacol, 2012, 144(2) : 300-304.
  • 6Nobili S, Landini 1, Mazzei T, et al. Overcoming tumor multidrug resistance using drugs able to e- vade P-gIycoprotein or to exploit its expression[J]. Med Res Rev, 2012, 32(6): 1220-1262.
  • 7Pluchino KM, Hall MD, Goldsborough AS, et al. Collateral sensitivity as a strategy against cancer multidrug resistance[J]. Drug Resist Updat, 2012, 15(1/2) : 98-105.
  • 8Wang Y, Hao D, Stein WD, et ah A kinetic study of Rhodamine 123 pumping by P-glycoprotein[J]. Biochim Biophys Acta, 2006, 1758(10): 1671- 1676.
  • 9Song P,Tang W,Tamura S,et al. The management of hepatocellular carcinoma in Asia: a guideline combining quantitative and qualitative evaluation[J]. Biosci Trends,2010,4(6) : 283-287.
  • 10Kohno K,Izumi H,Uehimni T.The pleiotropic functions ofthe Y-- box-binding protein YB- 1[J].Bioessays, 2003, 18 (25) : 691-698.

引证文献3

二级引证文献18

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部